A survey of all uses of medicines for children shows that the prescription of off-label and unauthorised drugs is still widespread in Europe, more than three years after the European Union legislation that aimed to end this practice came into force.

The survey was commissioned as part of the European Paediatric regulation, which is intended to improve children’s healthcare by encouraging the development and availability of medicines for children aged 0 to 17 years, ensuring they are...

This page is available to Science|Business Network Members only. If you are already a member then please log in (above).

Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.

Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.

Be where innovation begins – become a member. Click here to learn more.